LICENSE AGREEMENTLicense Agreement • May 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2012 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made effective this day of , 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2012 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made effective this 29th day of December, 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • February 24th, 2006 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 24th, 2006 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made effective this 29th day of December, 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”